Loading...

Case Report: Pathologic Complete Response to Pembrolizumab in Combination With Neoadjuvant Chemotherapy in a Patient With Stage IIB Squamous Lung Cancer

The emergence of PD-1 antibodies has radically changed the therapeutic profiles of lung cancer, which has the highest incidence and mortality rate among all cancers worldwide. Pembrolizumab, an anti-PD-1 antibody, has been proven to have strong anti-tumor activity in a variety of clinical studies. H...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Surg
Main Authors: Zhang, Lin, Mai, Wuqian, Jiang, Wenyang, Geng, Qing
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7728662/
https://ncbi.nlm.nih.gov/pubmed/33330611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fsurg.2020.601805
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!